![]() |
Digital Innovation Contest – Culture 2
The ‘Digital Innovation Contest – Culture 2’ – run by IC tomorrow in conjunction with the Design Museum and the Public, is procuring up to two trials – offering a maximum of £24,000 for each successful innovative commercial prototype in response to the following two challenges:
1. ‘Digital campaigning and fundraising challenge’ – set by the Design Museum – 1 award of £24,000.
2. ‘Fun and engaging gallery journeys challenge’ – set by the Public – 1 award of £24,000.
Successful applicants will also benefit from:
- collaborating with one of the two leading cultural partners
- an opportunity to promote their prototype via the IC tomorrow programme
- support in resolving content delivery, licensing and metadata issues related to the service or application
- retaining their intellectual property.
Register and Apply at:
https://connect.innovateuk.org/web/digital-innovation-contest-culture-2
Deadline for submissions – Noon, Monday 20 August 2012.
Open date: 09 July 2012
Close date: 20 August 2012
Email: competitions@innovateuk.org
Email: support@ictomorrow.co.uk
Phone number: 0300 321 4358
The RKE Operations team can help you with your application.












BU students’ publishing success
BU presentation at the University of Bristol
Art and Design: History, Practice and Theory academics – would you like to get more involved in preparing our next REF submission?
UKCGE Recognised Research Supervision Programme: Final Deadline Reminder
The significance of Rights and Protocols in Disaster Response
Horizon Europe Cluster 3 (Civil Security for Society) 2026 Calls Now Open
MSCA Doctoral Networks 2026 Call Information Webinar
ESRC Festival of Social Science 2026: Application Deadline Extended to Thursday 25 June 2026
Reminder: Register for the ESRC Festival of Social Science 2026 Information Session
ECR Funding Open Call: Research Culture & Community Grant – Apply now
ERC Advanced Grant 2025 Webinar
Update on UKRO services
European research project exploring use of ‘virtual twins’ to better manage metabolic associated fatty liver disease